Health committee  Not that I'm aware of from Health Canada. Health Canada can respond about what they're prepared to put on the table for that, but I know they are very much engaged—and certainly on the first nations side they are very present. The fact that they are having these discussions with FPT ministers of health and that it's in the throne speech and has expanded the reach of the national anti-drug strategy to allow for the inclusion of prescription drugs, I think, bodes well.

Health committee  Among the knowledge gaps I think there are three areas in particular that we can focus on. This again was a subject of the discussion with the FPT ministers of health. One is on prescription monitoring programs and the understanding of what exactly is occurring across the country in that regard.

Health committee  Thank you. I'll try to treat these, and if I miss one, please move back to me. First of all, I am delighted that you remember the committee of 2001, and it's important that we have that continuity at the table here.

Health committee  The first thing is that Nova Scotia took the lead in being co-chair of this process on behalf of the federal-provincial-territorial problematic substance use committee. They were our door into the PT process. The other co-chair was the College of Physicians and Surgeons of Alberta.

Health committee  Thank you. Good afternoon, Mr. Chair and members of the committee. My name is Michel Perron and I'm the chief executive officer of the Canadian Centre on Substance Abuse, or CCSA as I'll refer to it in my remarks. I'll extend my congratulations to you, Mr. Lobb, on your appointment as chair of the committee.